1

Higher Remission

What Sets Us Apart

Theta burst stimulation has consistently produced longer lasting results than conventional TMS with fewer side effects.

THETA BURST THERAPY

2

Read Our Research

Read Our Research

Open Label Study published in Brain Stimulation Journal.

ARTICLE IN PRESS

3

Get Help

Conditions We Treat

• Depression
• Tinnitus
• Bipolar Disorder



FIND TREATMENT NOW

4

New Patient

New Patients

Transcranial Magnetic Stimulation (TMS) is a novel form of Brain Stimulation used to treat patients whose condition(s) has not improved through conventional approaches.

GET STARTED

5

Success Stories

Recovery

Read about our patients' success stories. In a series of documented case studies by Dr. Stubbeman, see the effect of TMS as a treatment solution for conditions such as depression and tinnitus.

PATIENT CASE STUDIES

Latest News and Research

• 

  Study Uses Non-invasive Technique To Help Veterans With Depression, Concussion

  Promising studies using repetitive T to help veterans and active-duty service members living with depression, post-traumatic stress disorder (PTSD), and other lasting consequences of concussion.
  PermalinkNov 19 2020
• 

  Pilot Study: New Approach to Help Adults with Autism and Depression

  Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
  PermalinkNov 05 2020
• 

  Targeting Brain Circuits in TMS May Relieve Specific Symptoms of Depression

  Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
  PermalinkOct 22 2020
• 

  Intensive Brain Stimulation Lifts Depression In 90% of Patients

  Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
  PermalinkOct 08 2020
• 

  Large-Scale Analysis of Interindividual Variability in Theta-Burst Stimulation Data: Results From the ‘Big TMS Data Collaboration’

  Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
  PermalinkSep 15 2020
• 

  The Future Is Now? Rapid Advances by Brain Stimulation Innovation

  Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
  PermalinkSep 01 2020
• 

  Transcranial Magnetic Stimulation

  Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
  PermalinkAug 25 2020
• 

  Accelerated Intermittent Theta Burst Stimulation Treatment for Depression During COVID-19 Pandemic

  Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
  PermalinkAug 11 2020